← All trials
NCT00190580
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2003
- Primary completion
- Apr 1, 2008
- Completion date
- Apr 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 312
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- KVT-Study GroupLead sponsor
- St. Marianna University School of MedicineStudy chair
- Yokohama City UniversityCollaborator
- Showa UniversityCollaborator
- Kitasato UniversityCollaborator
- St. Marianna University School of MedicineCollaborator
- Tokai UniversityCollaborator
- KVT-Study GroupReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.